New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy

Canadian Journal of Cardiology

Volumn 18, Issue 12, 2002, Pages 1294-1300

  Murakami, Yo ^a   Shimada, Toshio ^a   Inoue, Shin Ichi ^a   Shimizu, Hiromi ^a   Ohta, Yoko ^a   Katoh, Harumi ^a   Nakamura, Ko ^a   Ishibashi, Yutaka ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Atria; Cardiomyopathy; Hypertension; Hypertrophy; Natriuretic polypeptides

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA;

ADULT; AGED; AORTA; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY SINUS; CORRELATION ANALYSIS; FEMALE; HEART ATRIUM; HEART ATRIUM PRESSURE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HEART VENTRICLE; HEART WORK; HUMAN; HYPERTENSION; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LUNG WEDGE PRESSURE; MALE; PREDICTION; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SYSTOLE; VEIN;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS;

EID: 0036993903     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kohno M, Horio T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
2. Nishigaki K, Tomita M, Kagawa K, et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1996;28:1234-42.
3. Hasegawa K, Fujiwara H, Doyama K, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88:372-80.
4. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-6.
5. Shimizu H, Murakami Y, Inoue S, et al. High plasma brain natriuretic polypeptide level as a marker of high risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 2002;33:1005-10.
6. Doyama K, Fukumoto M, Takemura G, et al. Expression and distribution of brain natriuretic peptide in human right atria. J Am Coll Cardiol 1998;32:1832-8.
7. Lunchner A, Stevens TL, Borgeson DD, et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 1998;274:H1684-9.
8. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993;87:464-9.
9. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-3.
10. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995;13:155-60.
11. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
12. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 1979;43:1242-4.
13. Ishibashi Y, Shimada T, Sakane T, et al. Contribution of endogenous nitric oxide to basal vasomotor tone of peripheral vessels and plasma B-type natriuretic peptides levels in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1605-11.
14. Ohta Y, Shimada T, Yoshitomi H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation. Can J Cardiol 2001;17:415-9.
15. Tharaux PL, Dussaule JC, Hubert-Brierre J, Vahanian A, Acar J, Ardailou R. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci 1994;87:671-7.
16. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
17. Brookes CO, Kemp MW, Hooper J, Oldershaw PJ, Moat NE. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997;6:608-12.
18. Takemura G, Takatsu Y, Doyama K, et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 1998;31:254-65.
19. Hintze TH, Wang J, Patel M, et al. Dynamics of atrial peptide secretion in the coronary circulation of the conscious dog. Circ Res 1990;67:609-14.
20. Marcus ML, Mueller TM, Gascho JA, et al. Effects of cardiac hypertrophy secondary to hypertension on the coronary circulation. Am J Cardiol 1979;44:1023-9.
21. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
22. Tan A, Russel FGM, Thien T, Benraad TJ. Atrial natriuretic peptide. An overview of clinical pharmacology and pharmacokinetics. Clin Pharmacokinet 1993;24:28-45.
23. Doyle DD, Upshaw-Earley J, Bell EL, et al. Natriuretic peptide receptor-B in adult rat ventricle is predominantly confined to the nonmyocyte population. Am J Physiol Hert Circ Physiol 2002;282:H2117-23.